Clinical Trial

Medicines in Breast Milk and Estimated Infant Exposure

Study acronym: MedMilk
Recruiting
View on ClinicalTrials.gov →
Summary
The MedMilk (Medication concentrations in human Milk) study investigates how selected medicines taken by breastfeeding women are transferred into human milk and whether this may affect the breastfed child. The study includes breastfeeding women who are already using prescription or over-the-counter medicines as part of their usual care. Participants provide samples of breast milk and urine and complete a questionnaire about maternal and infant health. The collected data will be used to quantify medicine concentrations in milk and estimate the relative infant dose. The study aims to contribute new data to support safer prescribing and more informed counselling during breastfeeding
Trial Details
NCT Number NCT07346716
Lead Sponsor University Hospital Bispebjerg and Frederiksberg
Conditions Breastfeeding, Medication Safety, Lactation, Drug Exposure Via Breast Milk, Pharmacokinetic Parameters
Enrollment 250 participants
Start Date 2024-12-20
Primary Completion 2028-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-16